Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE

Pale Fire Capital SE decreased its position in Liquidia Corporation (NASDAQ:LQDA) by 99.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,479 shares of the company’s stock after selling 384,898 shares during the quarter. Pale Fire Capital SE’s holdings in Liquidia were worth $277,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of LQDA. Farallon Capital Management LLC raised its position in Liquidia by 1.1% in the fourth quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock worth $298,547,000 after acquiring an additional 90,400 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Liquidia by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock worth $138,439,000 after purchasing an additional 52,671 shares in the last quarter. Opaleye Management Inc. lifted its stake in Liquidia by 9.5% during the second quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock valued at $30,838,000 after purchasing an additional 215,000 shares during the last quarter. Bank of America Corp DE lifted its stake in Liquidia by 18.7% during the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock valued at $86,341,000 after purchasing an additional 360,372 shares during the last quarter. Finally, TCG Crossover Management LLC bought a new stake in Liquidia during the third quarter worth approximately $38,887,000. Institutional investors own 64.54% of the company’s stock.

Insider Buying and Selling

In other news, insider Rajeev Saggar sold 50,000 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $74.06, for a total value of $3,703,000.00. Following the completion of the sale, the insider directly owned 142,265 shares in the company, valued at approximately $10,536,145.90. The trade was a 26.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jason Adair sold 73,631 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $69.09, for a total transaction of $5,087,165.79. Following the sale, the insider owned 174,606 shares of the company’s stock, valued at $12,063,528.54. This trade represents a 29.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,541,274 shares of company stock valued at $111,545,379. 25.60% of the stock is owned by corporate insiders.

Liquidia Stock Up 4.1%

LQDA stock opened at $69.68 on Thursday. The company has a 50 day moving average of $78.86 and a two-hundred day moving average of $57.83. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. Liquidia Corporation has a 12-month low of $21.15 and a 12-month high of $93.61. The company has a market cap of $6.24 billion, a price-to-earnings ratio of 50.86 and a beta of 0.53.

Liquidia (NASDAQ:LQDA) last issued its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.02). The firm had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. Liquidia had a return on equity of 149.65% and a net margin of 30.74%.The business’s revenue for the quarter was up 1842.1% on a year-over-year basis. During the same period in the previous year, the company earned ($0.49) earnings per share. On average, equities analysts anticipate that Liquidia Corporation will post 2.57 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on LQDA shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $60.00 price target on shares of Liquidia in a report on Monday, May 11th. Needham & Company LLC upped their target price on Liquidia from $70.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. BTIG Research increased their price target on Liquidia from $109.00 to $111.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. HC Wainwright set a $36.00 price objective on shares of Liquidia in a research note on Friday, July 24th. Finally, Lifesci Capital lowered shares of Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 price objective for the company. in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $98.08.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).